Eric Van Cutsem (E Van Cutsem)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 36

Top Topics

Locally Advanced

Metastatic Colorectal Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Kohei Shitara, Alfred Falcone, Marwan G Fakih, Ben George, Raghav Sundar, Sandip Ranjan, Eric Van Cutsem
Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic Review. The oncologist 29 (5) (2024)
Christos S Karapetis, H Liu, Michael J Sorich, L D Pederson, Eric Van Cutsem, Timothy S Maughan, J Y Douillard, C J O'Callaghan, D Jonker, C Bokemeyer, A Sobrero, Chiara Cremolini, B Chibaudel, Zalcberg John, R Adams, M Buyse, M Peeters, Takayuki Yoshino, A de Gramont, Q Shi
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database. British journal of cancer (2024)
Christos S Karapetis, H Liu, Michael J Sorich, L D Pederson, Eric Van Cutsem, Timothy S Maughan, J Y Douillard, C J O'Callaghan, D Jonker, C Bokemeyer, A Sobrero, Chiara Cremolini, B Chibaudel, Zalcberg John, R Adams, M Buyse, M Peeters, Takayuki Yoshino, A de Gramont, Q Shi
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database. British journal of cancer 130 (8) (2024)
Kohei Shitara, Alfred Falcone, Marwan G Fakih, Ben George, Raghav Sundar, Sandip Ranjan, Eric Van Cutsem
Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic Review. The oncologist 29 (5) (2024)
Kohei Shitara, Alfred Falcone, Marwan G Fakih, Ben George, Raghav Sundar, Sandip Ranjan, Eric Van Cutsem
Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic Review. The oncologist 29 (5) (2024)
Philip A Philip, Vaibhav Sahai, Nathan Bahary, Amit Mahipal, Anup Kasi Loknath Kumar, Caio Max S Rocha Lima, Angela T Alistar, Paul E Oberstein, Talia Golan, Jean-Phillippe Metges, Jill Lacy, Christos Fountzilas, Charles D Lopez, Michel Ducreux, Pascal Hammel, Mohamed E Salem, David Bajor, Al Bowen Benson, Sanjeev Luther, Timothy Pardee, Eric Van Cutsem
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Robert J Motzer, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Eric Van Cutsem, Salah-Eddin Al-Batran, Wasat Mansoor, Nicholas Maisey, Roberto A Pazo-Cid, Matthew Burge, David Perez-Callejo, R William Hipkin, Sourav Mukherjee, Ming Lei, Hao Tang, Satyendra Suryawanshi, Ronan J Kelly, Niall C Tebbutt
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Robert J Motzer, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Eric Van Cutsem, Salah-Eddin Al-Batran, Wasat Mansoor, Nicholas Maisey, Roberto A Pazo-Cid, Matthew Burge, David Perez-Callejo, R William Hipkin, Sourav Mukherjee, Ming Lei, Hao Tang, Satyendra Suryawanshi, Ronan J Kelly, Niall C Tebbutt
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Christos S Karapetis, H Liu, Michael J Sorich, L D Pederson, Eric Van Cutsem, Timothy S Maughan, J Y Douillard, C J O'Callaghan, D Jonker, C Bokemeyer, A Sobrero, Chiara Cremolini, B Chibaudel, Zalcberg John, R Adams, M Buyse, M Peeters, Takayuki Yoshino, A de Gramont, Q Shi
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database. British journal of cancer 130 (8) (2024)
Robert J Motzer, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Eric Van Cutsem, Salah-Eddin Al-Batran, Wasat Mansoor, Nicholas Maisey, Roberto A Pazo-Cid, Matthew Burge, David Perez-Callejo, R William Hipkin, Sourav Mukherjee, Ming Lei, Hao Tang, Satyendra Suryawanshi, Ronan J Kelly, Niall C Tebbutt
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Kohei Shitara, Alfred Falcone, Marwan G Fakih, Ben George, Raghav Sundar, Sandip Ranjan, Eric Van Cutsem
Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic Review. The oncologist (2024)
Robert J Motzer, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Eric Van Cutsem, Salah-Eddin Al-Batran, Wasat Mansoor, Nicholas Maisey, Roberto A Pazo-Cid, Matthew Burge, David Perez-Callejo, R William Hipkin, Sourav Mukherjee, Ming Lei, Hao Tang, Satyendra Suryawanshi, Ronan J Kelly, Niall C Tebbutt
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Christos S Karapetis, H Liu, Michael J Sorich, L D Pederson, Eric Van Cutsem, Timothy S Maughan, J Y Douillard, C J O'Callaghan, D Jonker, C Bokemeyer, A Sobrero, Chiara Cremolini, B Chibaudel, Zalcberg John, R Adams, M Buyse, M Peeters, Takayuki Yoshino, A de Gramont, Q Shi
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database. British journal of cancer 130 (8) (2024)
Kohei Shitara, Alfred Falcone, Marwan G Fakih, Ben George, Raghav Sundar, Sandip Ranjan, Eric Van Cutsem
Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic Review. The oncologist 29 (5) (2024)
Christos S Karapetis, H Liu, Michael J Sorich, L D Pederson, Eric Van Cutsem, Timothy S Maughan, J Y Douillard, C J O'Callaghan, D Jonker, C Bokemeyer, A Sobrero, Chiara Cremolini, B Chibaudel, Zalcberg John, R Adams, M Buyse, M Peeters, Takayuki Yoshino, A de Gramont, Q Shi
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database. British journal of cancer 130 (8) (2024)
Robert J Motzer, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Eric Van Cutsem, Salah-Eddin Al-Batran, Wasat Mansoor, Nicholas Maisey, Roberto A Pazo-Cid, Matthew Burge, David Perez-Callejo, R William Hipkin, Sourav Mukherjee, Ming Lei, Hao Tang, Satyendra Suryawanshi, Ronan J Kelly, Niall C Tebbutt
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Christos S Karapetis, H Liu, Michael J Sorich, L D Pederson, Eric Van Cutsem, Timothy S Maughan, J Y Douillard, C J O'Callaghan, D Jonker, C Bokemeyer, A Sobrero, Chiara Cremolini, B Chibaudel, Zalcberg John, R Adams, M Buyse, M Peeters, Takayuki Yoshino, A de Gramont, Q Shi
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database. British journal of cancer 130 (8) (2024)
Josep Tabernero, Eric Van Cutsem, Elena Garralda, David Tai, Filippo G De Braud, Ravit Geva, Mark T J van Bussel, Katia Fiorella Dotti, Elena Elez, María J de Miguel, Kevin Litwiler, Danielle Murphy, Michelle Edwards, Van Karlyle Morris
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer. The oncologist 28 (3) (2023)
Eric Van Cutsem, Gilles Manceau, Rona Yaeger, Takayuki Yoshino, Axel Grothey, Evaristo Maiello, Elena Elez, Jeroen Dekervel, Paul J Ross, Ana Ruiz-Casado, Janet Graham, Takeshi Kato, Jose Carlos Ruffinelli, Thierry André, Edith Carrière Roussel, Isabelle Klauck, Mélanie Groc, Jean-Claude Vedovato, Josep Tabernero
ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAF V600E -Mutant Metastatic Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Eric Van Cutsem, Rona Yaeger, Jean-Pierre Delord, Josep Tabernero, Lillian L Siu, Michel Ducreux, Salvatore Siena, Elena Elez Fernandez, Stefan Kasper, Thomas Zander, Neeltje Steeghs, Danielle Murphy, Michelle Edwards, Zev A Wainberg
Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer. The oncologist (2023)
Josep Tabernero, Eric Van Cutsem, Elena Garralda, David Tai, Filippo G De Braud, Ravit Geva, Mark T J van Bussel, Katia Fiorella Dotti, Elena Elez, María J de Miguel, Kevin Litwiler, Danielle Murphy, Michelle Edwards, Van Karlyle Morris
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer. The oncologist (2023)
Margaret A Tempero, Uwe Pelzer, Eileen M O'Reilly, Jordan M Winter, Do Youn Oh, Chung-Pin Li, Giampaolo Tortora, Heung-Moon Chang, Charles D Lopez, Tanios S Bekaii-Saab, Andrew H Ko, Armando Santoro, Joon Oh Park, Marcus S Noel, Giovanni Luca Frassineti, Yan-Shen Shan, Andrew Dean, Hanno Riess, Eric Van Cutsem, Jordan D Berlin, Philip Philip, Malcolm Moore, David Goldstein, Josep Tabernero, Mingyu Li, Stefano Ferrara, Yvan Le Bruchec, George Zhang, Brian Lu, Andrew V Biankin, Michele Reni, null null
Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Albert M Wolthuis, André D'Hoore, Eric Van Cutsem
Health-related quality of life in rectal cancer: a topic more relevant now than ever. BJS open 6 (6) (2022)
Albert M Wolthuis, André D'Hoore, Eric Van Cutsem
Health-related quality of life in rectal cancer: a topic more relevant now than ever. BJS open 6 (6) (2022)
Lin Shen, Ken Kato, Sung-Bae Kim, Jaffer A Ajani, Kuaile Zhao, Zhiyong He, Xinmin Yu, Yongqian Shu, Qi Luo, Jufeng Wang, Zhendong Chen, Zuoxing Niu, Longzhen Zhang, Tienan Yi, Jong-Mu Sun, Jianhua Chen, Guohua Yu, Chen-Yuan Lin, Hiroki Hara, Qing Bi, Taroh Satoh, Roberto A Pazo-Cid, Hendrick-Tobias Arkenau, Christophe Borg, Florian Lordick, Liyun Li, Ningning Ding, Aiyang Tao, Jingwen Shi, Eric Van Cutsem, null null
Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (26) (2022)
Albert M Wolthuis, André D'Hoore, Eric Van Cutsem
Health-related quality of life in rectal cancer: a topic more relevant now than ever. BJS open 6 (6) (2022)
Mohamed E Salem, Sherif M El-Refai, Wei Sha, Alberto Puccini, Axel Grothey, Thomas J George, Jimmy J Hwang, Bert O'Neil, Alexander S Barrett, Kunal C Kadakia, Laura W Musselwhite, Derek Raghavan, Eric Van Cutsem, Josep Tabernero, Jeanne Tie
Landscape of KRAS G12C , Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS -Mutated Cancers. JCO precision oncology 6 (2022)
Hedy Lee Kindler, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J Hall, Joon Oh Park, Daniel Hochhauser, Dirk Arnold, Do Youn Oh, Anke C Reinacher-Schick, Giampaolo Tortora, Hana Algül, Eileen M O'Reilly, Sonal Bordia, David McGuinness, Karen Y Cui, Gershon Y Locker, Talia Golan
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (34) (2022)
Eric Van Cutsem, I Danielewicz, M P Saunders, P Pfeiffer, G Argilés, C Borg, Robert Glynne-Jones, C J A Punt, A J Van de Wouw, M Fedyanin, D Stroyakovskiy, H Kroening, P Garcia-Alfonso, Harpreet S Wasan, A Falcone, R Fougeray, A Egorov, N Amellal, V Moiseyenko
First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study. British journal of cancer 126 (11) (2022)
Nadine Jackson McCleary, William S Harmsen, Ellana Haakenstad, James M Cleary, Jeffrey A Meyerhardt, Zalcberg John, Richard A Adams, Axel Grothey, Alberto F Sobrero, Eric Van Cutsem, Richard M Goldberg, Marc Peeters, Josep Tabernero, Matthew T Seymour, Leonard B Saltz, Bruce J Giantonio, Dirk Arnold, Mace L Rothenberg, Miriam Koopman, Hans-Joachim Schmoll, Henry C Pitot, Paulo M Hoff, Niall C Tebbutt, Gianluca Masi, John Souglakos, Carsten Bokemeyer, Volker Heinemann, Takayuki Yoshino, Benoist Chibaudel, Aimery deGramont, Qian Shi, Stuart M Lichtman
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials. JNCI cancer spectrum 6 (2) (2022)
An-Katrien Seghers, Pieter-Jan Cuyle, Eric Van Cutsem
Molecular Targeting of a BRAF Mutation in Pancreatic Ductal Adenocarcinoma: Case Report and Literature Review. Targeted oncology 15 (3) (2021)
J Randolph Hecht, Sara Lonardi, Johanna Bendell, Hao-Wen Sim, Teresa Macarulla, Charles D Lopez, Eric Van Cutsem, Andrés Muñoz Martin, Joon Oh Park, Richard Greil, Hong Wang, Rebecca R Hozak, Ivelina Gueorguieva, Yong Lin, Sujata Rao, Baek-Yeol Ryoo
Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (10) (2021)
Heinz-Josef Lenz, Eric Van Cutsem, Maria Luisa Limon, Ka Yeung Mark Wong, Alain Hendlisz, Massimo Aglietta, Pilar García-Alfonso, Bart Neyns, Gabriele Luppi, Dana Backlund Cardin, Tomislav Dragovich, Usman Shah, Sandzhar Abdullaev, Joseph Gricar, Jean-Marie Ledeine, Michael James Overman, Sara Lonardi
First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Stefano Cascinu, György Bodoky, Kei Muro, Eric Van Cutsem, Sang Cheul Oh, Gunnar Folprecht, Sumitra Ananda, Gustavo Girotto, Zev A Wainberg, Maria Luisa Limon Miron, Jaffer A Ajani, Ran Wei, Astra M Liepa, Roberto Carlesi, Michael Emig, Atsushi Ohtsu
Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric Cancer. The oncologist 26 (3) (2020)
Eric Van Cutsem, Manuel Hidalgo, Jean-Luc Canon, Teresa Macarulla, Igor Bazin, Elena Poddubskaya, Nebojsa Manojlovic, Dejan Radenkovic, Chris Verslype, Eric Raymond, Antonio Cubillo, Armin Schueler, Charles Zhao, Pascal Hammel
Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer. International journal of cancer 143 (8) (2018)
Karel Demey, Hans Van Veer, Philippe Nafteux, Christophe M Deroose, Karin Haustermans, Johan Coolen, Vincent Vandecaveye, Willy Coosemans, Eric Van Cutsem
Hepatic radiation injury mimicking metastasis in distal esophageal cancer. Acta chirurgica Belgica 117 (4) (2016)